Laboratorios Farmaceuticos Rovi, S.A.

LABFF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$76$27$23$32
Dep. & Amort.$7$7$7$7
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$37-$10-$2$73
Other Non-Cash$27-$15-$9-$40
Operating Cash Flow$73$9$19$73
Investing Activities
PP&E Inv.-$17-$12-$8-$29
Net Acquisitions$0$0-$3-$19
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1-$0-$0$1
Investing Cash Flow-$18-$12-$12-$47
Financing Activities
Debt Repay.-$6$20-$6-$16
Stock Issued$16$14$14$19
Stock Repurch.-$16-$14-$15-$19
Dividends Paid$0$0$0$0
Other Fin. Act.-$47-$1-$1-$1
Financing Cash Flow-$53$20-$7-$16
Forex Effect$0$0$0$0
Net Chg. in Cash$3$17$2$10
Supplemental Information
Beg. Cash$46$29$27$18
End Cash$49$46$29$27
Free Cash Flow$56-$3$11$45